Evolus, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the Annual Meeting of Stockholders held by Evolus, Inc. on June 8, 2022. The Company is an emerging growth company incorporated in Delaware, with its common stock (EOLS) trading on the Nasdaq Global Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and does not contain financial performance data.
Material Changes and Voting Results
Stockholders voted on two proposals at the Annual Meeting:
- Proposal 1 (Election of Directors): Stockholders elected David Gill, Robert Hayman, and Peter Farrell as Class I Directors for a three-year term ending in 2025.
- David Gill: 30,117,783 For; 4,396,089 Withhold; 7,724,389 Broker Non-Vote.
- Robert Hayman: 30,115,901 For; 4,397,971 Withhold; 7,724,389 Broker Non-Vote.
- Peter Farrell: 28,373,668 For; 6,140,204 Withhold; 7,724,389 Broker Non-Vote.
- Proposal 2 (Ratification of Auditors): Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2022.
- For: 42,167,313
- Against: 60,426
- Abstain: 10,522
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirmation of the new three-year terms for Directors Gill, Hayman, and Farrell.
- Verification of the ratification of Ernst & Young LLP as the independent auditor.
- Review of the definitive proxy statement filed on April 29, 2022, for detailed background on the proposals.